In terms of industry tailwinds, Trump could lessen pressure from the Federal Trade Commission on mergers and acquisitions, ...

PHILADELPHIA — The same technology that saved millions of lives during the COVID-19 pandemic appears to hold promise against another scourge of infectious disease, according to new research from the ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

Sanofi India Q3 Results Live : Sanofi India announced its Q3 results on November 7, 2024, revealing a significant decline in ...

The company’s domestic sales grew by over 15 per cent to Rs. 933 crore, driven by a consistent performance in its core ...

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical ...

An "Asthma Patient-Centered Precision Diagnosis and Treatment Expert Initiative" was initiated by experts in the field of ...

Winners received prestigious award in recognition of latest innovations in advancement in life sciences ...

A report from People's Daily: The 7th China International Import Expo (CIIE), the world's first import-themed national-level expo, being held in Shanghai from Nov. 5 to 10, is seeing its 'circle of ...

With numerous planned submissions underway for 2024, the new platform is setting a new standard for managing simultaneous ...

Dynavax is giving up work on its combination vaccine for tetanus, diphtheria and acellular pertussis (Tdap) after mulling phase 1 data for the shot. | Dynavax is giving up on its combination vaccine ...